Avalo Therapeutics, Inc.
AVTX
Revenue
0.00
▼-249.00k▼-100.00%
12 Months ChangeAssets
125.10M
▼-1.48M▼-1.17%
3 Months ChangeLiabilities
33.55M
▲11.54M▲52.45%
3 Months ChangeFree Cash Flow
-16.07M
▲2.27M▲12.38%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-01-12
Form 8-K
ID: 0001534120-26-000003
2025-12-02
Form 8-K
ID: 0001534120-25-000022
2025-11-06
Form 10-Q
ID: 0001534120-25-000018
2025-11-06
Form 8-K
ID: 0001534120-25-000017
2025-10-29
Form 8-K
ID: 0001534120-25-000013
2025-10-10
Form 8-K
ID: 0001534120-25-000011
2025-10-01
Form 8-K
ID: 0001534120-25-000009
2025-09-22
Form 8-K
ID: 0001534120-25-000005
2025-08-07
Form 10-Q
ID: 0001628280-25-038575
2025-08-07
Form 8-K
ID: 0001628280-25-038570